Monday, August 31, 2026

West Pharmaceutical And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 7, 2021

West Pharmaceutical  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - West Pharmaceutical (WST), Spirit Realty Capital (SRC), New York Times (NYT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. West Pharmaceutical (WST)

21.2% sales growth and 28.54% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical's sales growth this year is expected to be 30.4% and 8% for next year.

Year-on-year quarterly revenue growth grew by 37.3%, now sitting on 2.52B for the twelve trailing months.

Volume

Today's last reported volume for West Pharmaceutical is 987181 which is 165.13% above its average volume of 372332.

West Pharmaceutical's sales growth for the next quarter is 21.2%. The company's growth estimates for the current quarter and the next is 56.5% and 41.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.54%.

Volatility

West Pharmaceutical's last day, last week, and last month's current intraday variation average was 2.49%, 1.45%, and 1.17%, respectively.

West Pharmaceutical's highest amplitude of average volatility was 4.99% (day), 4.64% (last week), and 3.51% (last month), respectively.

West Pharmaceutical's Stock Yearly Top and Bottom Value

West Pharmaceutical's stock is valued at $442.66 at 05:22 EST, below its 52-week high of $475.35 and way higher than its 52-week low of $253.86.

West Pharmaceutical's Moving Average

West Pharmaceutical's worth is above its 50-day moving average of $424.76 and way above its 200-day moving average of $372.68.

2. Spirit Realty Capital (SRC)

16% sales growth and 4.36% return on equity

Spirit Realty Capital, Inc. (NYSE: SRC) is a premier net-lease REIT that primarily invests in single-tenant, operationally essential real estate assets, subject to long-term leases.

Spirit Realty Capital's sales growth this year is anticipated to be 24.6% and 9.2% for next year.

Year-on-year quarterly revenue growth grew by 34.3%, now sitting on 580.95M for the twelve trailing months.

Volume

Today's last reported volume for Spirit Realty Capital is 345863 which is 49.34% below its average volume of 682803.

Spirit Realty Capital's sales growth for the next quarter is 16%. The company's growth estimates for the present quarter and the next is 50% and 875%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.36%.

Volatility

Spirit Realty Capital's last day, last week, and last month's current intraday variation average was 2.78%, 1.91%, and 1.00%, respectively.

Spirit Realty Capital's highest amplitude of average volatility was 1.98% (day), 2.34% (last week), and 2.21% (last month), respectively.

Spirit Realty Capital's Stock Yearly Top and Bottom Value

Spirit Realty Capital's stock is valued at $45.24 at 05:22 EST, way below its 52-week high of $52.29 and way higher than its 52-week low of $36.01.

Spirit Realty Capital's Moving Average

Spirit Realty Capital's value is below its 50-day moving average of $48.07 and under its 200-day moving average of $47.35.

3. New York Times (NYT)

10.4% sales growth and 10.55% return on equity

New York Times's sales growth this year is expected to be 14% and 6.2% for next year.

Year-on-year quarterly revenue growth grew by 23.9%, now sitting on 1.88B for the twelve trailing months.

Volume

Today's last reported volume for New York Times is 638632 which is 53.72% below its average volume of 1380120.

New York Times's sales growth for the next quarter is 10.4%. The company's growth estimates for the ongoing quarter and the next is a negative 9.1% and negative -17.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.55%.

Volatility

New York Times's last day, last week, and last month's current intraday variation average was 1.93%, 1.54%, and 1.62%, respectively.

New York Times's highest amplitude of average volatility was 4.63% (day), 3.48% (last week), and 3.08% (last month), respectively.

New York Times's Stock Yearly Top and Bottom Value

New York Times's stock is valued at $47.47 at 05:22 EST, way below its 52-week high of $58.73 and way above its 52-week low of $38.06.

New York Times's Moving Average

New York Times's worth is below its 50-day moving average of $52.16 and higher than its 200-day moving average of $46.98.

Previous days news about New York Times(NYT)

  • According to FXStreet on Thursday, 2 December, "On the other hand, the New York Times (NYT) quotes Federal Reserve Bank of New York President John C. Williams as saying, "Omicron could prolong supply and demand mismatches, causing some inflation pressures to last."

4. Aon plc (AON)

5.4% sales growth and 51.83% return on equity

Aon plc, a professional services firm, provides advice and solutions to clients focused on risk, retirement, and health worldwide.

Aon plc's sales growth this year is expected to be 9.7% and 5.3% for next year.

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 11.76B for the twelve trailing months.

Volume

Today's last reported volume for Aon plc is 478173 which is 63.41% below its average volume of 1306850.

Aon plc's sales growth for the next quarter is 5.4%. The company's growth estimates for the present quarter and the next is 10.5% and 29.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.83%.

Volatility

Aon plc's last day, last week, and last month's current intraday variation average was 1.57%, 1.42%, and 0.95%, respectively.

Aon plc's highest amplitude of average volatility was 1.55% (day), 2.56% (last week), and 2.21% (last month), respectively.

Aon plc's Stock Yearly Top and Bottom Value

Aon plc's stock is valued at $292.89 at 05:22 EST, way under its 52-week high of $326.25 and way above its 52-week low of $197.86.

Aon plc's Moving Average

Aon plc's value is below its 50-day moving average of $301.69 and higher than its 200-day moving average of $268.78.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com